Canada Orthopedic Implants Market Size & Outlook, 2025-2033
Canada Orthopedic Implants Market Insights
- As per Reed Intelligence insights, the Canada Orthopedic Implants Market stood at USD 1932.65 Million in 2024 and is anticipated to grow to USD 3029.33 Million by 2033.
- The Canada market is expected to advance at a CAGR of 5.15% from 2025 through 2033.
- In 2024, Reconstructive Joint Replacements accounted for the highest share of the By Product market size.
- During the forecast period, Orthobiologic is set to register the highest growth, making it the most lucrative By Product segment.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- Canada accounted for 7.45% of the global Orthopedic Implants Market size in 2024.
- By 2033, United States is expected to remain the top global market in terms of size.
- Within North America, United States is forecasted to dominate the regional Orthopedic Implants Market size by 2033.
- United States will be the fastest-growing market in North America, projected to achieve USD 12402.88 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 1932.65 Million |
| Market Size In 2033 | USD 3029.33 Million |
| Largest segment | Reconstructive Joint Replacements |
| Units | Revenue in USD Million |
| CAGR | 5.15% (2025-2033) |
| Segmnetation Covered | |
| By Product |
|
| By Biomaterial |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Canada Orthopedic Implants Market By Product 2025-2033 (USD Million)
| By Product | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reconstructive Joint Replacements | XX.x | XX.x | XX.x | 644.54 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Spinal Implants | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Dental Implants | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Trauma and Craniomaxillofacial | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Orthobiologic | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Canada Orthopedic Implants Market By Biomaterial 2025-2033 (USD Million)
| By Biomaterial | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Metallic | XX.x | XX.x | XX.x | 820.6 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ceramic | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Polymeric | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Natural | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
